Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles

Autoimmune diseases affect over 40 million people in the United States. The cause of most autoimmune diseases is unknown; therefore, most therapies focus on treating the symptoms. This review will focus on the autoimmune diseases type 1 diabetes (T1D) and multiple sclerosis (MS) and the emerging rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, M., Hayter, E., Martin, R.S., Spence, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
VSI: Autoimmune disorder
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418496/
https://www.ncbi.nlm.nih.gov/pubmed/36039310
http://dx.doi.org/10.1016/j.jtauto.2022.100161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418496/
https://www.ncbi.nlm.nih.gov/pubmed/36039310
http://dx.doi.org/10.1016/j.jtauto.2022.100161

Ejemplares similares